baber/WOPTO huggingface dataset:
Patent DE-602005000049-T2 (DE)
Inventor: LEVANDER OSKAR
IPC: B63J3/02
Filed: 2005-01-13
Granted: 2007-04-19
Abstract: Barge arrangement comprising a barge unit (2) provided with a load carrying facility and a tug unit (4) provided with a propulsion system (5). In order to provide for a flexible and effective LNG transportation system, the barge unit (2) is provided with a LNG-receptacle (21) and a first power generating means (3) at least partly run by means of LNG boil-off gas. The tug unit (4) is provided with a propulsion system (5) and a second power generating means (6) for providing power to the propulsion system. In a first mode of the barge arrangement (1), in which the barge unit (2) and tug unit (4) are connected to each other, the propulsion system (5) of the tug unit (4) is arranged to be powered at least partly by the first power generating means (3) of the barge unit (2). This is advantageously done by providing the barge unit (2) with a first power connection element (34) which is connectable to a second power connection element (58) on the tug unit (4). The invention also relates to a barge unit (2) and a tug unit (4). <IMAGE>
Patent DE-602005000675-T2 (DE)
Inventor: BADWAN ADNAN
IPC: A61K9/22
Filed: 2005-01-19
Granted: 2007-11-15
Abstract: The present invention is directed to a controlled-release pharmaceutical composition providing a sustained delivery of the basic drug Terbutaline sulfate, said composition comprising at least Terbutaline sulfate or a derivative thereof as an active agent, and further comprising an inactive matrix, said matrix comprising a hydrophilic polysaccharide polymer mixture, said mixture comprising chitosan or a derivative thereof, and further comprising xanthan gum or a derivative thereof, wherein the ratio of xanthan gum and chitosan within said mixture is in the range from about 1:10 to about 10:1, and said composition optionally comprising sodium bicarbonate.
Patent DE-602005000962-T2 (DE)
Inventor: GUILLEZ JEAN-MARC
IPC: B60J10/90
Filed: 2005-06-29
Granted: 2007-11-15
Abstract: The device has an actuator (35) that is disposed and acting in a median vertical longitudinal plane (30), through movement of its rod. The actuator is connected to at least one roof panel (15b) for toppling the panel. The actuator is situated between two seats at level of backrest of the seats. The rod is connected in an articulated manner to an intermediate driving tube (49) that is directly connected to the panel. An independent claim is also included for a convertible vehicle with roof movable between closed and open positions.
Patent DE-602005003374-T2 (DE)
Inventor: BREDEHORST REINHARD PROF DR
IPC: C12Q1/68
Filed: 2005-10-17
Granted: 2008-09-11
Abstract: The invention relates to a method for determining an unknown PNA sequence information of PNA molecules of a specific PNA molecule species, wherein, the PNA molecules are contacted with one or several different nucleic acid molecule species comprising nucleic acid molecules with at least one nucleotide, wherein the nucleic acid molecules at least partially comprise a nucleic acid sequence that is complementary to at least a partial sequence of the PNA molecule, wherein nucleic acid molecules having complementary sequences bind to the PNA molecules forming nucleic acid/PNA hybrids, wherein nucleic acid molecules with non-complementary sequences are separated from the nucleic acid/PNA hybrids, wherein thereafter the nucleic acid/PNA hybrids are dissociated into single stranded hybrid nucleic acid molecules and PNA molecules, wherein the single stranded hybrid nucleic acid molecules are subjected to a sequencing process providing hybrid sequence information about the single stranded hybrid nucleic acid sequence, and wherein the hybrid sequence information is optionally translated into the complementary PNA sequence information, and to a method for producing PNA molecules using such a process.
Patent DE-602005005542-T2 (DE)
Inventor: MARTIN GUENAELLE
IPC: A61Q1/02
Filed: 2005-03-22
Granted: 2009-05-07
Abstract: Anhydrous make up or skin care composition (A) comprises a liquid organic phase containing at least a nonvolatile oil (I), amorphous gelling polymer (II) formed by polymerization of an olefine, and polymethylmethacrylate particles (the content of (I) is higher than (II)). An independent claim is also included for make-up foundation comprising (A).
Patent DE-69007797-T3 (DE)
Inventor: LARGUIER RENE
IPC: B60L50/10
Filed: 1990-12-17
Granted: 2004-05-27
Abstract: The power unit for a vehicle includes a thermal engine (1) and an electric motor (2). At low speed, the electric motor (2) has a driving torque higher than the thermal engine's (1) load moment. The electric motor (2) is designed to operate without being mechanically disconnected from the thermal engine (1) when the latter is running at its operating speed. In particular, the electric motor makes it possible to replace the starting motor, the alternator, and the flywheel of the thermal engine, and to provide additional or independent propulsion.
Patent DK-1183495-T3 (DK)
Inventor: BRYDGES-PRICE RICHARD IAN
IPC: F42B10/50
Filed: 2000-05-23
Granted: 2004-08-09
Abstract: A projectile mainly for drug delivery comprises a tubular body casing 1 which defines a cavity 2 for containment of a tranquilizing drug. The casing has an end plug 3 which coaxially supports a hollow needle 4 projecting forward through an ogival nose cap 5 . The delivery end 6 of the needle 4 projects a short way beyond the cap 5 . Located around the needle 4 towards the tip of the nose cap 5 is a gas producing detonator 7 fired by an impact fuse 8 . Attached to the detonator 7 and the needle 4 is the neck g of an inflatable bag 10 of which an opposed end 11 is attached to the plug 3 . The rear end of the cavity 2 has a piston 12 the rear end of which communicates through concentric passageways 13 and ducts 14 with the interior of the bag 10 . The nose cap 5 is of a readily breakable plastics material or designed to assist retardation.
Patent DK-1206183-T3 (DK)
Inventor: SCHUER JOERG
IPC: A01N31/02
Filed: 2000-08-28
Granted: 2006-09-18
Abstract: The invention relates to a method for impregnating, incorporating or surface-treating substances/articles that can be microbially decomposed, contaminated and/or infested with parasites and/or that are perishable. The inventive method comprises the following steps: applying a special antimicrobial/antiparasite composition on the substances/articles or incorporating the antimicrobial/antiparasite composition in the substances. The invention further relates to said special antimicrobial/antiparasite compositions, to their use for impregnating and/or surface-treating substances that can be microbially decomposed, contaminated and/or that are perishable or substances that are infested with parasites and to the use thereof in substances and products that have to be self-contaminating.
Patent DK-1240706-T3 (DK)
Inventor: MAGYAR PETER
IPC: H02P1/28
Filed: 2000-12-19
Granted: 2005-11-21
Abstract: The invention relates to a method for operating a 3-phase controller circuit, especially a soft start device for 3-phase motors, with a controllable semi-conductor circuit (2) in two of its three phase branches (L1-T1, L2-T2, L3-T3), respectively. The problem with known methods for controlling asymmetrically constructed circuits of this type are the unwanted side affects, such as torque fluctuations, that occur in motors to be controlled or similar. The invention solves this problem by providing that the two semiconductor circuits (2) of the phase branches to be controlled are controlled asymmetrically.
Patent DK-1167452-T3 (DK)
Inventor: ESSELBORN EBERHARD
IPC: C09K23/52
Filed: 2001-06-05
Granted: 2005-01-31
Abstract: Phosphate mono- and di-esters (I) of mono(cyclo)alkyl ethers of block copolymers of styrene oxide, ethylene oxide and optionally propylene oxide and/or butylene oxide and their salts are new. New phosphate mono- and di-esters (I) of mono(cyclo)alkyl ethers of block copolymers of styrene oxide, ethylene oxide and optionally propylene oxide and/or butylene oxide and their salts are of the formula (I): (R<1>O(SO)a(EO)b(CH2CHCH3O)c(BO)d)xPO-(OH)3-x R<1> = a 1-22 C linear, branched or cycloaliphatic group; SO = styrene oxide; EO = ethylene oxide; BO = butylene oxide; a = 1 to less than 2; b = 3-100; c = 0-10; d = 0-3; x = 1 or 2; b = more than (a+c+d)
Patent DK-1193104-T3 (DK)
Inventor: PANIZZOLO FABRIZIO
IPC: B60K17/36
Filed: 2001-09-18
Granted: 2007-06-11
Abstract: An engine half-trolley (10) of simplified structure for industrial vehicles set at the side of a vehicle chassis and comprising a casing (12) from which there comes out at least one wheel hub (13) for a respective wheel (14), an input shaft (17) to said half-trolley (10) being connected to a differential (16) of the vehicle, in the said half-trolley, between the input shaft (17) and the wheel hub (13), there being provided, in succession, two bevel-gear pairs (18, 19; 21, 23) housed in an arm (15, 115) forming part of the casing (12), in which at least one bottom area of the arm (15, 115), for attachment to the wheel hub (13), has ample bevels (26). <IMAGE>
Patent DK-1309395-T3 (DK)
Inventor: KOSOLA ANTTI
IPC: B01J2/16
Filed: 2001-08-10
Granted: 2007-06-18
Abstract: A fluidized bed coating apparatus is provided and includes a fluid inlet adapted to be connected to a source of fluidizing fluid. The fluid inlet has an entrance opening having a first diameter and an exit opening downstream of the entrance opening. The exit opening has a second diameter that is larger than the first diameter. The inlet also includes an expanding inlet section, between the entrance opening and the exit opening, that has an average diameter that increases in a direction from said entrance opening to said exit opening. A fluid distribution plate is provided adjacent the exit opening and includes a plurality of through-passages to allow the even and distributed passage of a fluidizing fluid therethrough. A chamber having a chamber inlet and a chamber outlet is provided and the fluid distribution plate is positioned between the exit opening and the chamber inlet. The chamber includes at least a first diverging section having an average diameter that increases in the direction from the chamber inlet downstream toward the chamber outlet. The symmetrical design of the coater provides an evenly distributed flow of fluid that enables efficient and complete fluidization and coating of very large particle beds.
Patent DK-1354567-T3 (DK)
Inventor: SHOHER ITZHAK
IPC: A61C5/77
Filed: 2002-04-17
Granted: 2009-03-02
Abstract: A dental material and method for forming a dental coping wherein the material has a plurality of layers with at least one layer composed of a base material composition containing high fusing temperature metal particles and with at least another layer being composed of a filler material composition of low fusing temperature metal particles arranged in an alternating sequence such that upon firing of the laminated structure in a furnace at a temperature at least equal to the melting temperature of the low fusing temperature metal particles but below the melting temperature of the high fusing temperature metal particles diffusion occurs from the filler layers into the base layers to bring the base layers together to form a solid structure.
Patent DK-1269966-T3 (DK)
Inventor: HAFEMANN KLAUS
IPC: A61H7/00
Filed: 2002-06-21
Granted: 2006-04-03
Abstract: The device (1) is assembled of two containers (2) filled with water (4, 4') for the accommodation of the feet during the treatment, joined with a bridge (3) fitted with appliances (6) for additional care. An electric drive (7) is located in the space (10) underneath the bridge (3) and is provided with a four way connector (11) for joining the coupling (12) belonging to the massaging device (18) accommodated in the stationary housing (13). The actual massaging or other foot care equipment (18) can be attached or removed without the need to disassemble the complete device (6).
Patent DK-1409390-T3 (DK)
Inventor: BLOCH HANSPETER
IPC: B66B11/04
Filed: 2002-07-23
Granted: 2006-05-15
Abstract: An assembly arrangement for a lift construction supports the lift drive at the upper end of both a support column and lift cage and counterweight guide rails, allowing the lift drive load to be transferred to the floor of the lift by each of the supporting members. The support of the lift drive upon the rails may be accomplished through setting screws that allow the load applied to the rails to be adjusted.
Patent DK-1423714-T3 (DK)
Inventor: HASHIMOTO HIROYUKI
IPC: G01C19/56
Filed: 2002-09-02
Granted: 2006-11-06
Abstract: A microstructure includes a mass; a base member in which the mass is movably contained. The mass includes a surface, which is exposed out of the base member, and a stopper wire, which is arranged above the surface of the mass so as to inhibit over move of the mass.
Patent DK-1450792-T3 (DK)
Inventor: CHVATCHKO YOLANDE
IPC: A61P9/10
Filed: 2002-12-06
Granted: 2007-01-29
Abstract: The present invention is related to the use of benzazole derivatives of formula (I) for the treatment and/or prevention of scleroderma and its therapeutic implications selected in the group consisting of systemic sclerosis, scleroderma-like disorders, sine scleroderma, liver cirrhosis, interstitial pulmonary fibrosis, Dupuytren's contracture, keloid and other scarring/wound healing abnormalities, postoperative adhesions and reactive fibrosis, as well as chronic heart failure, in particular after myocardial infarction.
Patent DK-1490405-T3 (DK)
Inventor: LANCASTER JOANNE SLOAN
IPC: A61P31/04
Filed: 2003-03-12
Granted: 2007-12-27
Abstract: Human antibodies, preferably recombinant human antibodies that specifically bind to human Fas Ligand (hFasL) are disclosed. These antibodies have high affinity for hFasL, a slow off rate for hFasL dissociation and neutralize a Fas Ligand activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antigen-binding portions, of the invention are useful for neutralizing Fas Ligand activity, e.g., in a human subject suffering from a disorder in which hFas Ligand activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant anti-hFasL human antibodies, and the methods for synthesizing the recombinant human antibodies are also encompassed by the invention.
Patent DK-1515791-T3 (DK)
Inventor: SIEFERT ROLF
IPC: B01J8/00
Filed: 2003-06-10
Granted: 2011-11-14
Abstract: To reduce the content of NO 2 and NOx in process and exhaust gases, they are passed over two catalyst beds (4,5) in succession, containing one or more zeolites charged with iron, between the gas inflow (1) and outflow (2). An agent for the reduction of NOx is fed (3) into a mixer (6) between the catalyst beds, and the bed temperatures are set at = 500 [deg] C. The gas pressure is adjusted to at least 2 bar in both beds. The spatial speed is selected through the ring channel gaps (7-10) at the beds, so that the NO 2 content is degraded in the first bed at the most by 90 % of its content on the entry of the gas into the bed and is degraded in the second bed by at least 30 % of the content on entering the second bed.
Patent DK-1562867-T3 (DK)
Inventor: GAID ABDELKADER
IPC: C02F1/52
Filed: 2003-11-21
Granted: 2007-01-15
Abstract: Material purged by the membrane filtration stage, is separated into two fractions. The first contains more than 60 wt% of activated carbon in preferably 20 wt% or less of water, the carbon containing organic matter and micro-pollutants. The second fraction contains preferably 20-40 times more water, and includes organics which are not absorbed on the carbon. The first fraction is recycled ahead of the stage in which the water is contacted with carbon.  An Independent claim is included for the corresponding waste water or potable water treatment plant.
Patent DK-1582204-T3 (DK)
Inventor: MILTON NATHANIAL
IPC: A61K38/00
Filed: 2000-03-02
Granted: 2013-11-04
Abstract: Pharmaceutical formulations are described comprising an echinocandin compound or echinocandin/carbohydrate complex and a pharmaceutically acceptable micelle-forming surfactant in a non-toxic aqueous solvent such that the solubilization of the echinocandin compound is optimized and the ability to freeze-dry the solution is maintained. Both the solution and freeze-dried formulations have increased stability. A bulking agent, tonicity agent buffer and/or a stabilizing agent may optionally be added to the formulations to further enhance the stability of the formulation.
Patent DK-1737731-T3 (DK)
Inventor: HENRIKSEN JOERGEN
IPC: B65B55/08
Filed: 2005-04-20
Granted: 2009-01-26
Abstract: The invention relates to a web of interconnected closure blanks (2) or membranes (20) formed in a flat sheet of flexible material, wherein adjacent closure blanks or membranes abut each other along weakened portions of the sheet and are separable along said weakened portions, and wherein a shape of each closure blank or membrane is defined by said weakened portions and the rims of the sheet so that the web contains no material in excess of the closure blanks or membranes.
Patent DK-1691127-T3 (DK)
Inventor: FARESE DAVID JOHN
IPC: F17C5/06
Filed: 2006-01-16
Granted: 2010-03-29
Abstract: The invention provides a method for supplying a cryogenic fluid to a network of two or more cryogenic fluid receiving stations, wherein a cryogenic liquid is routed to cryogenic fluid receiving stations in a single cryogenic vessel and is dispensed to the cryogenic fluid receiving stations as either a cryogenic liquid, a compressed gas, both a cryogenic liquid and a compressed gas, or as a mixture of a cryogenic liquid and a compressed gas.
Patent DK-1816214-T3 (DK)
Inventor: HOGAN KIRK
IPC: G01N33/50
Filed: 2001-07-10
Granted: 2008-10-27
Abstract: The present invention relates to methods for perioperative genomic screening of subjects, in particular to perioperative screening for markers indicative of responses to anesthesia during a surgical procedure. The present invention also provides kits comprising reagents for said screening and a computer program to analyze data derived from use of said reagents. The methods and kits of the present invention find use in tailoring a subject's medical or surgical treatment to reflect genetic information that predicts a subject's response to medications to techniques used in the procedure.
Patent DK-1871341-T3 (DK)
Inventor: DASSEUX JEAN-LOUIS H
IPC: A61K9/127
Filed: 2006-03-23
Granted: 2012-06-18
Abstract: The present disclosure provides charged lipoprotein complexes that include as one component a negatively charged phospholipid that is expected to impart the complexes with improved therapeutic properties.
Patent DK-2033575-T3 (DK)
Inventor: MALKOWSKY ANDREA
IPC: A61B5/296
Filed: 2008-08-07
Granted: 2010-11-08
Abstract: The method involves forming symmetrically and identically designed electrode bodies (6) on a polyethylene foam sheet (1) that is conveyed as an endless sheet article in grid dimension (A). The article is cut at its longitudinal sides so that a distance between longitudinal edges and central axes of the bodies amounts to half of the grid dimension. A cutting- or separating line is laid centrally between the bodies so that a distance from an edge to a geometric middle axis of the adjacent electrode body at three side edges of polyelectrodes (7) amounts to the half of the grid dimension. An independent claim is also included for an electrode system comprising polyelectrodes.
Patent DK-2190770-T3 (DK)
Inventor: HENSELER MARKUS
IPC: B66B5/00
Filed: 2008-09-05
Granted: 2012-03-26
Abstract: This elevator car (10) is characterized by a car roof (9), which is designed to be non-load bearing, so that in the uppermost position of the car (10) the required free space F in the form of a cuboid lying on one of the sides thereof and having the minimum dimensions of 0.5 m×0.6 m×0.8 m is located completely inside the car (10) and extends down to the car floor (8). When a potential load is applied onto the car roof (9), it yields or is lowered due to deformation. In this way, the required free space F of 0.6 m×0.5 m×0.8 m above the surface on which a maintenance technician can stand is ensured in any case as a safety space against the danger of crushing, even if the elevator car moves very close to the ceiling of the shaft.
Patent DK-2235096-T3 (DK)
Inventor: MAYERES JEAN-PIERRE
IPC: C08J9/00
Filed: 2009-01-23
Granted: 2012-01-23
Abstract: The invention relates to a method for making a fireproof polymer foam, and to a fireproof polymer foam containing a mixture of a polymer composition containing one or more optionally-substituted, sequenced or random, thermoplastic and/or elastomer homopolymers, copolymers or mixtures thereof, from 0.05 to 10 wt %, preferably from 0.5 to 5 wt %, relative to the mixture, of carbon nanotubes, and from 0.05 to 15 wt %, preferably from 0.5 to 10 wt %, relative to the mixture, of red phosphorus.
Patent DK-2260423-T3 (DK)
Inventor: BESHAN ERAN
IPC: G16H20/17
Filed: 2009-04-03
Granted: 2018-06-06
Abstract: A system for optimizing a patient's insulin dosage regimen over time, comprising at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen, and data inputs corresponding at least to the patient's blood-glucose-level measurements determined at a plurality of times, and a processor operatively connected to the at least first memory. The processor is programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components in the patient's present insulin dosage regimen in order to maintain the patient's future blood-glucose-level measurements within a predefined range.
Patent DK-2630263-T3 (DK)
Inventor: HICKS JAMES
IPC: C12Q1/6886
Filed: 2011-10-21
Granted: 2018-07-23
Abstract: A method for obtaining from genomic material genomic copy number information unaffected by amplification distortion, comprising obtaining segments of the genomic material, tagging the segments with substantially unique tags to generate tagged nucleic acid molecules, such that each tagged nucleic acid molecule comprises one segment of the genomic material and a tag, subjecting the tagged nucleic acid molecules to amplification by polymerase chain reaction (PCR), generating tag associated sequence reads by sequencing the product of the PCR reaction, assigning each tagged nucleic acid molecule to a location on a genome associated with the genomic material by mapping the subsequence of each tag associated sequence read corresponding to a segment of the genomic material to a location on the genome, and counting the number of tagged nucleic acid molecules having a different tag that have been assigned to the same location on the genome, thereby obtaining genomic copy number information unaffected by amplification distortion.
Patent DK-2790705-T3 (DK)
Inventor: COOKE NIGEL GRAHAM
IPC: A61P33/00
Filed: 2012-12-14
Granted: 2018-03-12
Abstract: The invention relates to new uses of PI3K inhibitors, wherein said inhibitors have an inhibitory action on the PI3K isoform delta for the treatment of immunopathology in a subject suffering from a disease or disorder selected from malaria, leishmaniasis, trypanosomiasis, toxoplasmosis and/or neurocysticercosis, via functional inhibition of TLR9 of the infected subject.